Skip to main content
. 2023 Mar 20;13(1):40. doi: 10.1038/s41408-023-00807-9

Fig. 5. Effect of the combination of at least two novel agents in the first line in progression-free survival.

Fig. 5

A Effect of the combination of at least two novel agents in the first line in progression-free survival in the t(11;14) group. B Effect of the combination of at least two novel agents in the first line in progression-free survival in the standard risk group. C Effect of the combination of at least two novel agents in the first line in progression-free survival in the high-risk chromosomal abnormalities group.